MyD88-Dependent SHIP1 Regulates Proinflammatory Signaling Pathways in Dendritic Cells after Monophosphoryl Lipid A Stimulation of TLR4

作者: Caglar Cekic , Carolyn R. Casella , Duygu Sag , Frann Antignano , Joseph Kolb

DOI: 10.4049/JIMMUNOL.1001034

关键词: IκB kinaseTLR4BiologyProinflammatory cytokineTRIFMyeloid Differentiation Factor 88Lipid ACell biologyImmunologySignal transductionMonophosphoryl Lipid A

摘要: We previously showed that monophosphoryl lipid A (MLA) activates TLR4 in dendritic cells (DCs) a Toll/IL-1R domain-containing adaptor inducing IFN-β (TRIF)–biased manner: MLA produced from Salmonella minnesota Re595 induced signaling events and expression of gene products were primarily TRIF dependent, whereas MyD88-dependent was impaired. Moreover, when tested TRIF-intact/MyD88-deficient DCs, synthetic the Escherichia coli chemotype (sMLA) same activity as its diphosphoryl, inflammatory counterpart (synthetic diphosphoryl A), indicating TRIF-mediated is fully by sMLA. Unexpectedly, we found transcript level one proinflammatory cytokine increased sMLA-treated MyD88 deficiency to higher A, which suggested may paradoxically help restrain TRIF-biased In this article, demonstrate sMLA induces recruitment anti-inflammatory phosphatase SHIP1 an manner. At time, at IL-1R–associated kinase 1 markedly reduced. Increased associated with reductions sMLA-induced IκB α/β IFN regulatory factor 3 activation restrained their downstream targets, endothelin-1 IFN-β, respectively. Results study identify pattern desirable context vaccine adjuvant design: can stimulate partial activity, helping reduce DCs.

参考文章(35)
Laura M Sly, Victor Ho, Frann Antignano, Jens Ruschmann, Melisa Hamilton, Vivian Lam, Michael J Rauh, Gerald Krystal, The role of SHIP in macrophages Frontiers in Bioscience. ,vol. 12, pp. 2836- 2848 ,(2007) , 10.2741/2276
Hua Shen, Bethany M Tesar, Wendy E Walker, Daniel R Goldstein, Dual Signaling of MyD88 and TRIF Is Critical for Maximal TLR4-Induced Dendritic Cell Maturation Journal of Immunology. ,vol. 181, pp. 1849- 1858 ,(2008) , 10.4049/JIMMUNOL.181.3.1849
Yoon Sun Kim, Zee Yong Park, So Young Kim, Eunshil Jeong, Joo Young Lee, Alteration of Toll-like receptor 4 activation by 4-hydroxy-2-nonenal mediated by the suppression of receptor homodimerization. Chemico-Biological Interactions. ,vol. 182, pp. 59- 66 ,(2009) , 10.1016/J.CBI.2009.07.009
Jay T Evans, Christopher W Cluff, David A Johnson, Michael J Lacy, David H Persing, Jory R Baldridge, Enhancement of antigen-specific immunity via the TLR4 ligands MPL adjuvant and Ribi.529 Expert Review of Vaccines. ,vol. 2, pp. 219- 229 ,(2003) , 10.1586/14760584.2.2.219
Mark R. Alderson, Patrick McGowan, Jory R. Baldridge, Peter Probst, TLR4 agonists as immunomodulatory agents. Journal of Endotoxin Research. ,vol. 12, pp. 313- 319 ,(2006) , 10.1179/096805106X118753
Ryan M O'Connell*, Aadel A Chaudhuri*, Dinesh S Rao*, David Baltimore, * Equal-contrib, Inositol phosphatase SHIP1 is a primary target of miR-155. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 106, pp. 7113- 7118 ,(2009) , 10.1073/PNAS.0902636106
Shizuo Akira, Satoshi Uematsu, Osamu Takeuchi, Pathogen Recognition and Innate Immunity Cell. ,vol. 124, pp. 783- 801 ,(2006) , 10.1016/J.CELL.2006.02.015
Taro Kawai, Osamu Adachi, Tomohiko Ogawa, Kiyoshi Takeda, Shizuo Akira, Unresponsiveness of MyD88-Deficient Mice to Endotoxin Immunity. ,vol. 11, pp. 115- 122 ,(1999) , 10.1016/S1074-7613(00)80086-2
Paul Baldrick, Derek Richardson, Gary Elliott, Alan W. Wheeler, Safety evaluation of monophosphoryl lipid A (MPL): an immunostimulatory adjuvant Regulatory Toxicology and Pharmacology. ,vol. 35, pp. 398- 413 ,(2002) , 10.1006/RTPH.2002.1541
Nathalie Garçon, Patrick Chomez, Marcelle Van Mechelen, GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives Expert Review of Vaccines. ,vol. 6, pp. 723- 739 ,(2007) , 10.1586/14760584.6.5.723